We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Some Australian drugmakers are still figuring out how to pass muster during the Therapeutic Goods Administration (TGA)’s new pharmacovigilance inspections introduced in 2017, according to the TGA’s first metrics report. Read More
The FDA released a final guidance on pediatric labeling of prescription drugs that, among other recommendations, calls for black box warnings on medicines with inactive ingredients that might be dangerous to babies and children. Read More
The European Medicines Agency on Tuesday released another update on its efforts to avoid drug shortages in the event that the UK crashes out of the union without a formal deal. Read More
Gilead subsidiary Asegua Therapeutics won the exclusive contract to treat Louisiana’s poor and imprisoned hepatitis C patients, health officials in the Pelican State announced Tuesday. Read More
Purdue and its owners on Tuesday agreed to pay $270 million to settle a lawsuit bought by Oklahoma officials, avoiding what would have been the first jury trial in a nationwide opioid crisis that may end up costing drugmakers billions. Read More